Prolonged treatment with finasteride (a 5α-reductase inhibitor) does not affect bone density and metabolism
November 1992
in “Clinical Endocrinology”
TLDR Long-term finasteride use doesn't change bone density or metabolism.
The study aimed to evaluate the effect of finasteride, a 5α-reductase inhibitor, on bone density and metabolism in elderly men. The results showed that prolonged treatment with finasteride did not affect bone density or mineral metabolism, except for a small increase in 1,25(OH)₂D3 serum concentration. The study suggests that finasteride is a safe drug as pertains to bone and mineral metabolism.
View this study on onlinelibrary.wiley.com →
Cited in this study
research The clinical development of a 5α-reductase inhibitor, finasteride
Finasteride effectively treats BPH, but needs more trials to understand potential.
Related
research Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.
Finasteride doesn't affect hormone levels in normal men.